{"id":966653,"date":"2026-05-26T07:03:34","date_gmt":"2026-05-26T11:03:34","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/idexx-expands-fecal-dx-antigen-testing-platform-with-taeniidtapeworm-detection\/"},"modified":"2026-05-26T07:03:34","modified_gmt":"2026-05-26T11:03:34","slug":"idexx-expands-fecal-dx-antigen-testing-platform-with-taeniidtapeworm-detection","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/idexx-expands-fecal-dx-antigen-testing-platform-with-taeniidtapeworm-detection\/","title":{"rendered":"IDEXX Expands Fecal Dx Antigen Testing Platform with TaeniidTapeworm Detection"},"content":{"rendered":"

<\/p>\n

IDEXX Expands Fecal Dx Antigen Testing Platform with TaeniidTapeworm Detection<\/b><\/p>\n

Third menu expansion in four years broadens intestinal parasite detection in routine care<\/i><\/p>\n

WESTBROOK, Maine–(BUSINESS WIRE<\/a>)–IDEXX Laboratories, Inc.<\/a> (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the expansion of its Fecal Dx\u2122antigen testing platform with taeniid tapeworm, including Taenia<\/i> and Echinococcus <\/i>species. Proven to detect up to twice as many intestinal parasite infections earlier than fecal flotation alone,1<\/sup> Fecal Dx antigen testing delivers broader parasite detection in a single test for both wellness and sick-pet care.<\/p>\n

This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20260526203257\/en\/<\/a><\/p>\n

\"IDEXX<\/p>\n

IDEXX Fecal Dx\u2122 antigen testing platform menu<\/p>\n<\/div>\n

\nSince launching in 2012, more than 50 million Fecal Dx antigen tests have been run worldwide,2 <\/sup>reflecting strong clinical adoption over time. With each menu expansion, Fecal Dx has grown into a scalable diagnostic platform with increasing clinical scope and practice value.<\/p>\n

\n\u201cThis advancement reflects how we innovate at IDEXX, developing platforms that grow with our customers as care evolves,\u201d said Mike Erickson, President and CEO of IDEXX. \u201cBy broadening the insight available through Fecal Dx, we\u2019re making fecal testing easier to incorporate into everyday decision-making, helping veterinary teams reach more pets with greater confidence.\u201d<\/p>\n

Taenia<\/i> and Echinococcus<\/i> species are recognized by the Companion Animal Parasite Council (CAPC) as clinically important parasites,3,4<\/sup> with growing relevance for veterinarians worldwide. In particular, in areas where Echinococcus <\/i>speciesis endemic, it can pose a significant zoonotic risk and remains a notable concern in parts of Europe, the United States and Canada. With this addition, Fecal Dx antigen testing now detects seven of the most clinically relevant intestinal parasite groups, including hookworm, roundworm, whipworm, flea tapeworm, taeniid tapeworm, Cystoisospora<\/i> and Giardia<\/i> (in select panels).<\/p>\n

\n\u201cThe addition of taeniid tapeworm detection to IDEXX Fecal Dx makes this an even more complete intestinal parasite screen for cats and dogs,\u201d said Michael Rose, DVM, Managing Owner, Monticello Animal Hospital.* \u201cThis allows veterinarians to institute medical treatment early, which helps protect pet health and reduce zoonotic risk to owners.\u201d<\/p>\n

\nBeginning in late June, Fecal Dx antigen testing panels and profiles for IDEXX Reference Laboratories customers in the United States and Canada will automatically include detection of taeniid tapeworm at no additional cost.<\/p>\n

\nFor more information, please visit the Fecal Dx antigen testing<\/a> web page.<\/p>\n

*<\/b>Dr. Rose has received compensation for consulting services he has provided to IDEXX.<\/p>\n\n\n\n\n\n\n
\n

References<\/b><\/p>\n<\/td>\n<\/tr>\n

\n

\n1.<\/p>\n<\/td>\n

\n

\nBurton KW, Michael H, Drake C. The utility of coproantigen testing in screening populations. Vet Parasitol<\/i>. 2025;336:110459. doi:10.1016\/j.vetpar.2025.110459<\/p>\n<\/td>\n<\/tr>\n

\n

\n2.<\/p>\n<\/td>\n

\n

\nData on file at IDEXX Laboratories, Inc. Westbrook, Maine USA: IDEXX Fecal Dx antigen test results collected January 2012\u2013April 2026.<\/p>\n<\/td>\n<\/tr>\n

\n

\n3.<\/p>\n<\/td>\n

\n

\nCompanion Animal Parasite Council. CAPC guidelines: Taenia<\/i> spp. Updated February 7, 2025. Accessed May 5, 2026. www.capcvet.org\/guidelines\/taenia<\/a><\/p>\n<\/td>\n<\/tr>\n

\n

\n4.<\/p>\n<\/td>\n

\n

\nCompanion Animal Parasite Council. CAPC guidelines: Echinococcus<\/i> spp. Updated February 7, 2025. Accessed May 5, 2026. www.capcvet.org\/guidelines\/echinococcus-spp<\/a><\/p>\n<\/td>\n<\/tr>\n<\/table>\n

About IDEXX<\/strong><\/p>\n

\nIDEXX is a global leader in pet healthcare innovation. Our diagnostic and software products and services create clarity in the complex, constantly evolving world of veterinary medicine. We support longer, fuller lives for pets by delivering insights and solutions that help the veterinary community around the world make confident decisions\u2014to advance medical care, improve efficiency, and build thriving practices. Our innovations also help ensure the safety of milk and water across the world and maintain the health and well-being of people and livestock. IDEXX Laboratories, Inc. is a member of the S&P 500\u2122 Index. Headquartered in Maine, IDEXX employs approximately 11,000 people and offers solutions and products to customers in more than 175 countries and territories. For more information about IDEXX, visit: www.idexx.com<\/a>.<\/p>\n

Note Regarding Forward-Looking Statements<\/b><\/p>\n

\nThis news release contains or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by the use of words such as \u201cexpects,\u201d \u201cmay,\u201d \u201canticipates,\u201d \u201cintends,\u201d \u201cwould,\u201d \u201cwill,\u201d \u201cplans,\u201d \u201cbelieves,\u201d \u201cestimates,\u201d \u201cshould,\u201d \u201cproject,\u201d and similar words and expressions. These forward-looking statements are intended to provide our current expectations or forecasts of future events; are based on current estimates, projections, beliefs, and assumptions; and are not guarantees of future performance. Actual events or results may differ materially from those described in the forward-looking statements. These statements are subject to risks, uncertainties, assumptions, and other important factors. Readers are cautioned not to put undue reliance on such forward-looking statements because actual results may vary materially from those expressed or implied. The reports filed by IDEXX pursuant to United States securities laws contain discussions of some of these risks and uncertainties. IDEXX assumes no obligation to, and expressly disclaims any obligation to, update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Readers are advised to review IDEXX\u2019s filings with the United States Securities and Exchange Commission (which are available from the SEC\u2019s EDGAR database at sec.gov and via IDEXX\u2019s website at idexx.com).<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20260526203257\/en\/<\/a><\/span><\/p>\n

Media Relations
\n<\/b>
media@idexx.com
\n<\/a><\/p>\n

Investor Relations
\n<\/b>
investorrelations@idexx.com<\/a><\/p>\n

KEYWORDS:<\/b> United States North America Maine<\/p>\n

INDUSTRY KEYWORDS:<\/b> Science Veterinary Other Science Research Pets Health Consumer Clinical Trials<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n\n\n\n
Photo<\/b><\/font><\/td>\n<\/tr>\n
\"Photo\"<\/td>\n<\/tr>\n
IDEXX Fecal Dx\u2122 antigen testing platform menu<\/font><\/td>\n<\/tr>\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

IDEXX Expands Fecal Dx Antigen Testing Platform with TaeniidTapeworm Detection Third menu expansion in four years broadens intestinal parasite detection in routine care WESTBROOK, Maine–(BUSINESS WIRE)–IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the expansion of its Fecal Dx\u2122antigen testing platform with taeniid tapeworm, including Taenia and Echinococcus species. Proven to detect up to twice as many intestinal parasite infections earlier than fecal flotation alone,1 Fecal Dx antigen testing delivers broader parasite detection in a single test for both wellness and sick-pet care. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20260526203257\/en\/ IDEXX Fecal Dx\u2122 antigen testing platform menu Since launching in 2012, more than 50 million Fecal Dx antigen tests have … <\/p>\n

Continue reading “IDEXX Expands Fecal Dx Antigen Testing Platform with TaeniidTapeworm Detection”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-966653","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nIDEXX Expands Fecal Dx Antigen Testing Platform with TaeniidTapeworm Detection - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/idexx-expands-fecal-dx-antigen-testing-platform-with-taeniidtapeworm-detection\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IDEXX Expands Fecal Dx Antigen Testing Platform with TaeniidTapeworm Detection - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"IDEXX Expands Fecal Dx Antigen Testing Platform with TaeniidTapeworm Detection Third menu expansion in four years broadens intestinal parasite detection in routine care WESTBROOK, Maine–(BUSINESS WIRE)–IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the expansion of its Fecal Dx\u2122antigen testing platform with taeniid tapeworm, including Taenia and Echinococcus species. Proven to detect up to twice as many intestinal parasite infections earlier than fecal flotation alone,1 Fecal Dx antigen testing delivers broader parasite detection in a single test for both wellness and sick-pet care. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20260526203257\/en\/ IDEXX Fecal Dx\u2122 antigen testing platform menu Since launching in 2012, more than 50 million Fecal Dx antigen tests have … Continue reading "IDEXX Expands Fecal Dx Antigen Testing Platform with TaeniidTapeworm Detection"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/idexx-expands-fecal-dx-antigen-testing-platform-with-taeniidtapeworm-detection\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-26T11:03:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20260526203257\/en\/2813085\/4\/IDEXX_Fecal_Dx_Antigen_Testing_Platform_Menu.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/idexx-expands-fecal-dx-antigen-testing-platform-with-taeniidtapeworm-detection\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/idexx-expands-fecal-dx-antigen-testing-platform-with-taeniidtapeworm-detection\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"IDEXX Expands Fecal Dx Antigen Testing Platform with TaeniidTapeworm Detection\",\"datePublished\":\"2026-05-26T11:03:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/idexx-expands-fecal-dx-antigen-testing-platform-with-taeniidtapeworm-detection\\\/\"},\"wordCount\":880,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/idexx-expands-fecal-dx-antigen-testing-platform-with-taeniidtapeworm-detection\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260526203257\\\/en\\\/2813085\\\/4\\\/IDEXX_Fecal_Dx_Antigen_Testing_Platform_Menu.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/idexx-expands-fecal-dx-antigen-testing-platform-with-taeniidtapeworm-detection\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/idexx-expands-fecal-dx-antigen-testing-platform-with-taeniidtapeworm-detection\\\/\",\"name\":\"IDEXX Expands Fecal Dx Antigen Testing Platform with TaeniidTapeworm Detection - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/idexx-expands-fecal-dx-antigen-testing-platform-with-taeniidtapeworm-detection\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/idexx-expands-fecal-dx-antigen-testing-platform-with-taeniidtapeworm-detection\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260526203257\\\/en\\\/2813085\\\/4\\\/IDEXX_Fecal_Dx_Antigen_Testing_Platform_Menu.jpg\",\"datePublished\":\"2026-05-26T11:03:34+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/idexx-expands-fecal-dx-antigen-testing-platform-with-taeniidtapeworm-detection\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/idexx-expands-fecal-dx-antigen-testing-platform-with-taeniidtapeworm-detection\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/idexx-expands-fecal-dx-antigen-testing-platform-with-taeniidtapeworm-detection\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260526203257\\\/en\\\/2813085\\\/4\\\/IDEXX_Fecal_Dx_Antigen_Testing_Platform_Menu.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260526203257\\\/en\\\/2813085\\\/4\\\/IDEXX_Fecal_Dx_Antigen_Testing_Platform_Menu.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/idexx-expands-fecal-dx-antigen-testing-platform-with-taeniidtapeworm-detection\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IDEXX Expands Fecal Dx Antigen Testing Platform with TaeniidTapeworm Detection\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IDEXX Expands Fecal Dx Antigen Testing Platform with TaeniidTapeworm Detection - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/idexx-expands-fecal-dx-antigen-testing-platform-with-taeniidtapeworm-detection\/","og_locale":"en_US","og_type":"article","og_title":"IDEXX Expands Fecal Dx Antigen Testing Platform with TaeniidTapeworm Detection - Market Newsdesk","og_description":"IDEXX Expands Fecal Dx Antigen Testing Platform with TaeniidTapeworm Detection Third menu expansion in four years broadens intestinal parasite detection in routine care WESTBROOK, Maine–(BUSINESS WIRE)–IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the expansion of its Fecal Dx\u2122antigen testing platform with taeniid tapeworm, including Taenia and Echinococcus species. Proven to detect up to twice as many intestinal parasite infections earlier than fecal flotation alone,1 Fecal Dx antigen testing delivers broader parasite detection in a single test for both wellness and sick-pet care. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20260526203257\/en\/ IDEXX Fecal Dx\u2122 antigen testing platform menu Since launching in 2012, more than 50 million Fecal Dx antigen tests have … Continue reading \"IDEXX Expands Fecal Dx Antigen Testing Platform with TaeniidTapeworm Detection\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/idexx-expands-fecal-dx-antigen-testing-platform-with-taeniidtapeworm-detection\/","og_site_name":"Market Newsdesk","article_published_time":"2026-05-26T11:03:34+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20260526203257\/en\/2813085\/4\/IDEXX_Fecal_Dx_Antigen_Testing_Platform_Menu.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/idexx-expands-fecal-dx-antigen-testing-platform-with-taeniidtapeworm-detection\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/idexx-expands-fecal-dx-antigen-testing-platform-with-taeniidtapeworm-detection\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"IDEXX Expands Fecal Dx Antigen Testing Platform with TaeniidTapeworm Detection","datePublished":"2026-05-26T11:03:34+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/idexx-expands-fecal-dx-antigen-testing-platform-with-taeniidtapeworm-detection\/"},"wordCount":880,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/idexx-expands-fecal-dx-antigen-testing-platform-with-taeniidtapeworm-detection\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260526203257\/en\/2813085\/4\/IDEXX_Fecal_Dx_Antigen_Testing_Platform_Menu.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/idexx-expands-fecal-dx-antigen-testing-platform-with-taeniidtapeworm-detection\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/idexx-expands-fecal-dx-antigen-testing-platform-with-taeniidtapeworm-detection\/","name":"IDEXX Expands Fecal Dx Antigen Testing Platform with TaeniidTapeworm Detection - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/idexx-expands-fecal-dx-antigen-testing-platform-with-taeniidtapeworm-detection\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/idexx-expands-fecal-dx-antigen-testing-platform-with-taeniidtapeworm-detection\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260526203257\/en\/2813085\/4\/IDEXX_Fecal_Dx_Antigen_Testing_Platform_Menu.jpg","datePublished":"2026-05-26T11:03:34+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/idexx-expands-fecal-dx-antigen-testing-platform-with-taeniidtapeworm-detection\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/idexx-expands-fecal-dx-antigen-testing-platform-with-taeniidtapeworm-detection\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/idexx-expands-fecal-dx-antigen-testing-platform-with-taeniidtapeworm-detection\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20260526203257\/en\/2813085\/4\/IDEXX_Fecal_Dx_Antigen_Testing_Platform_Menu.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20260526203257\/en\/2813085\/4\/IDEXX_Fecal_Dx_Antigen_Testing_Platform_Menu.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/idexx-expands-fecal-dx-antigen-testing-platform-with-taeniidtapeworm-detection\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"IDEXX Expands Fecal Dx Antigen Testing Platform with TaeniidTapeworm Detection"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/966653","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=966653"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/966653\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=966653"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=966653"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=966653"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}